Found 3365 matching trials
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma PHASE2 This study will address the question of whether targeting CMV antigens with...
Show More Location
Children's Hospital Colorado
Learn More & Join Trial
A Safety And Immunogenicity Study Of A 13-valent Pneumococcal Conjugate Vaccine In Japanese Subjects Aged 6 To 64 Years. PHASE3 This study is to evaluate the safety, tolerability and immunogenicity of a ...
Show More Learn More & Join Trial
A Study to Evaluate the Safety and Immunogenicity of 4 Doses of MenACWY Conjugate Vaccine, Administered Concomitantly With Routine Vaccines, Among Infants Aged 2 Months PHASE3 This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Show More Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Learn More & Join Trial
Entolimod on Immunosenescence in Healthy Geriatric Subjects Receiving Influenza Vaccination PHASE2 Researchers are evaluating the safety and effectiveness of a single adminis...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial
Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Infants PHASE3 The purpose of this study is to assess the safety, tolerability and immunog...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Immunogenicity Study of GSK's Clostridium Difficile Vaccine 2904545A When Administered in Healthy Adults Aged 18-45 Years and 50-70 Years PHASE1 The purpose of this study is to generate safety, reactogenicity (assessment...
Show More Location
GSK Investigational Site
Learn More & Join Trial
The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults PHASE1 Vaccines are one of our most effective public health tools but many who nee...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
9-valent CRM 197 Pneumococcal PHASE2 The purpose of this study is to evaluate the safety and immune response of ...
Show More Location
University of Rochester
Learn More & Join Trial
Study to Assess the Safety and Immunogenicity of a Chikungunya Virus Vaccine Candidate (VLA1553) in Healthy Volunteers PHASE1 Randomized, observer-blinded, multicenter, dose-escalation Phase 1 clinical...
Show More Location
Optimal Research, LLC
Learn More & Join Trial
A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer PHASE1 Background:
* PSA (prostate specific antigen) is a protein found on normal...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial